Eosinophilia as an adverse drug reaction secondary to thalidomide therapy in Lepra type 2 reactions: a mandate responsibility

Eosinophilia as an adverse drug reaction secondary to thalidomide therapy in Lepra type 2 reactions: a mandate responsibility

Limited data are available on eosinophilia as a drug adverse event with immunosuppressant and modulator. We report a case  of 40 year old male patient treated with thalidomide for lepra reaction developed thalidomide induced eosinophilia. Eosinophil count rose during thalidomide treatment and decrea...

Full description

Bibliographic Details
Main Authors: Deeptanshu Nirmal Chandu, Pugazhenthan Thangaraju, Sajitha Venkatesan, Shoban Babu Varthya
Format: Article
Language:English
Published: Cukurova University 2019-12-01
Series:Cukurova Medical Journal
Subjects:
adverse effect
thalidomide
esinophils
adverse event
eosinophilia
Online Access:https://dergipark.org.tr/tr/download/article-file/813104

Similar Items

Similar Items